Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 16.631% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
[a] COc1ccc(CN(C)C(=O)C2CSC3(C)CCC(=O)N23)cc1OC
[b] CS(=O)(=O)Nc1ccc(C2=NN(C(=O)c3ccco3)C(c3ccccc3)C2)cc1
[c] Cl.OCCN1CCN(CC(O)COc2ccc(C34CC5CC(CC(C5)C3)C4)cc2)CC1
[d] COC(=O)c1ccc2c(=O)n(CC3CCCO3)c(SCC(=O)NCCc3ccc(S(N)(=O)=O)cc3)nc2c1
[e] Cc1cc2ncn(C(=O)N3CCOCC3)c2cc1C
Answer: e. Cc1cc2ncn(C(=O)N3CCOCC3)c2cc1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc2ncn(C(=O)N3CCOCC3)c2cc1C
Cc1cc2ncn(C(=O)N3CCOCC3)c2cc1C
(5,6-dimethylbenzimidazol-1-yl)-morpholin-4-ylmethanone